Lendormin

Brotizolam, the active ingredient in Lendormin, is a benzodiazepine presented as a tablet for oral use. It treats insomnia in adult patients. GNH USA supplies Lendormin as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Brotizolam is a benzodiazepine sedative‑hypnotic used primarily in the management of sleep disorders.

Insomnia (sleep onset): reduces the time required to fall asleep in adults. Insomnia (sleep maintenance): decreases the number of nocturnal awakenings. Insomnia associated with anxiety: improves overall sleep quality while calming anxiety symptoms.

Brotizolam may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Drowsiness - Dizziness - Headache - Fatigue - Memory impairment - Muscle weakness

Serious or Rare Side Effects: - Respiratory depression - Dependence or withdrawal syndrome - Paradoxical agitation or aggression - Severe allergic reactions (rash, swelling) - Depression or suicidal thoughts - Significant hypotension

Before prescribing Brotizolam, clinicians should consider several safety factors.

Assess patient history: evaluate for respiratory disorders, liver impairment, or renal dysfunction. Avoid use in elderly: increased risk of falls and cognitive impairment. Monitor for dependence: limit duration of therapy and assess for signs of misuse. Do not combine with alcohol: additive central nervous system depression. Pregnancy and lactation: use only if clearly needed after risk–benefit assessment. Store at ambient temperature: keep in the original pack, protect from moisture.

Brotizolam can interact with other substances that affect the central nervous system.

Major Interactions (Avoid): - Alcohol: additive CNS depression leading to severe sedation. - Opioids: heightened risk of respiratory depression and profound sedation. - Other benzodiazepines: excessive sedation and impaired psychomotor function.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): may increase overall sedation. - Antihistamines: can enhance drowsiness and dizziness. - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may raise Brotizolam plasma concentrations.